Kehua Biotech, China 

Kehua Biotech, based in China, has established two integrated R&D and innovation platforms dedicated to clinical in vitro diagnostic reagents and fully automated analytical instruments, enabling coordinated development of both reagents and systems. The company’s portfolio spans immunodiagnostics, clinical biochemistry, molecular diagnostics, and point-of-care testing, supported by a strong regulatory footprint with more than 260 NMPA registrations and over 80 CE-marked reagent and instrument products.